Jonathan Biller insider trades

Open-market stock purchases and sales by Jonathan Biller, EVP and Chief Legal Officer at Vertex Pharmaceuticals Inc / MA, from SEC Form 4 filings since Jul 30, 2018.

Recent trades

DateStockTradeValue
Feb 25, 2026VRTX Vertex Pharmaceuticals Inc / MASold$460K
Feb 24, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$555K
Feb 18, 2026VRTX Vertex Pharmaceuticals Inc / MASold$589K
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$728K
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MASold$1.2M
Feb 13, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$1.5M
Feb 13, 2026VRTX Vertex Pharmaceuticals Inc / MASold$493K
Feb 11, 2026VRTX Vertex Pharmaceuticals Inc / MASold$886K
Feb 10, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$764K
Jan 22, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Jan 22, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Dec 3, 2025VRTX Vertex Pharmaceuticals Inc / MASold$156K
Oct 2, 2025VRTX Vertex Pharmaceuticals Inc / MASold$281K

Companies traded

  • VRTX Vertex Pharmaceuticals Inc / MA: 12 sales, last Feb 25, 2026
  • AGIO Agios Pharmaceuticals, Inc: other filings, last Mar 1, 2022
  • CELG Celgene Corp /de/: other filings, last Nov 20, 2019

Get free alerts when Jonathan Biller files a new trade →